Articles with "weeks treatment" as a keyword



Photo from wikipedia

Lower extremity intermittent negative pressure for intermittent claudication. Follow-up after 24 weeks of treatment.

Sign Up to like & get
recommendations!
Published in 2021 at "Annals of vascular surgery"

DOI: 10.1016/j.avsg.2021.03.016

Abstract: INTRODUCTION Treatment with lower extremity intermittent negative pressure (INP) of -40 mmHg for one hour twice daily for 12 weeks, increases walking capacity in patients with intermittent claudication (IC). However, the effects of INP treatment… read more here.

Keywords: lower extremity; treatment; weeks treatment; mwd ... See more keywords
Photo by schluditsch from unsplash

Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B

Sign Up to like & get
recommendations!
Published in 2019 at "Medicine"

DOI: 10.1097/md.0000000000016683

Abstract: Abstract Interferon-alpha (IFN-α) is currently the preferred antiviral treatment for children with chronic hepatitis B (CHB) aged >1-year-old. However, the evidence regarding the exact efficacy and safety in the real world is not sufficient. This… read more here.

Keywords: treatment; children chronic; weeks treatment; interferon alpha ... See more keywords
Photo from archive.org

Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta‐analysis from the GetGoal programme

Sign Up to like & get
recommendations!
Published in 2017 at "Diabetes"

DOI: 10.1111/dom.12810

Abstract: To evaluate the long‐term efficacy and safety of lixisenatide, a short‐acting, prandial glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) as add‐on therapy in type 2 diabetes mellitus. read more here.

Keywords: type diabetes; diabetes mellitus; weeks treatment; effect lixisenatide ... See more keywords
Photo from wikipedia

IDDF2018-ABS-0105 No resistance to TENOFOVIR ALAFENAMIDE detected through 96 weeks of treatment in patients with chronic hepatitis B

Sign Up to like & get
recommendations!
Published in 2018 at "Gut"

DOI: 10.1136/gutjnl-2018-iddfabstracts.207

Abstract: Background Presented herein are the post Week 48 through Week 96 resistance analyses for 2 Phase 3 studies evaluating tenofovir alafenamide (TAF) versus tenofovir disoproxil fumarate(TDF) for the treatment of chronic hepatitis B (CHB) in… read more here.

Keywords: week; treatment; site substitutions; weeks treatment ... See more keywords
Photo by papaioannou_kostas from unsplash

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Endocrinology"

DOI: 10.3389/fendo.2023.1140196

Abstract: Objective To analyze the efficacy of mycophenolate mofetil (MMF) and glucocorticoid administration in patients with thyroid-associated ophthalmopathy (TAO). Methods Sixty patients with moderate to severe TAO treated in Jingzhou Central Hospital from January 2022 to… read more here.

Keywords: weeks treatment; experimental group; group; control group ... See more keywords
Photo from wikipedia

Influence of CYP2D6 and CYP3A5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Bisoprolol in Hypertensive Chinese Patients

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Medicine"

DOI: 10.3389/fmed.2021.683498

Abstract: Purpose: This study was performed to investigate the effects of common polymorphisms in CYP2D6 and CYP3A5 on the plasma concentrations and antihypertensive effects of bisoprolol in hypertensive Chinese patients. Methods: One hundred patients with essential… read more here.

Keywords: cyp2d6; weeks treatment; cyp2d6 cyp3a5; cyp3a5 polymorphisms ... See more keywords
Photo from wikipedia

Cost-Effectiveness of Testing for NS5A Resistance to Optimize Treatment of Elbasvir/Grazoprevir for Chronic Hepatitis C in China

Sign Up to like & get
recommendations!
Published in 2021 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2021.717504

Abstract: Objectives: Baseline presence of nonstructural protein 5A (NS5A) resistance-associated variants can attenuate the efficacy of new direct-acting antivirals. A potential method to attain the higher efficacy would be to screen for NS5A polymorphisms prior to… read more here.

Keywords: treatment; hepatitis china; weeks treatment; treatment testing ... See more keywords